Medical Condition News

RSS

UH researcher receives $2 million to develop drugs for traditionally undruggable targets in cancer

With a $2 million recruitment grant from the Cancer Prevention and Research Institute of Texas, a University of Houston researcher is setting up a lab to develop drugs that will work on traditionally undruggable targets in cancer.

2 Mar 2022

Study finds new benchmark for measuring the risk of death from heart surgery

A large international study has found an important new benchmark for measuring the risk of death for patients undergoing heart surgery, of which there are two million adults a year globally.

2 Mar 2022

Novel MRI approach can identify brain cell damage in people at early stages of Alzheimer's

Alzheimer's disease usually is diagnosed based on symptoms, such as when a person shows signs of memory loss and difficulty thinking.

2 Mar 2022

Exposure to more green space during the pandemic linked to less depression and anxiety

People exposed to more green space during the first year of the COVID-19 pandemic reported significantly less depression and anxiety, according to new University of Colorado Boulder research published March 2 in the journal PLOS One.

2 Mar 2022

Researchers propose potential fixes to develop evidence-based diagnostic criteria for FMDs

Functional Movement Disorders (FMDs) are common and disabling conditions. With an increasing research interest in FMDs, including the emergence of intervention trials, it is crucial to examine research methodology and develop standardized protocols.

2 Mar 2022

Nicotinamide riboside supplement shows promise as a potential therapy for Parkinson’s disease

Nicotinamide riboside (NR) is amember of the vitamin B3 family, which can be found in foods like fruits, vegetables, meat, and milk. It is also used as a nutritional supplement to boost cellular levels of NAD (nicotinamide adenine dinucleotide).

2 Mar 2022

Crowdfunding helps young cancer survivors to pay medical bills, but at a cost

Crowdfunding has become a means for people with cancer to get help managing the financial impact of their disease. But while there's relief in paying bills, a new study finds that it comes at a cost: a sense of shame and stigma from asking for help and revealing personal health details.

2 Mar 2022

Using Hla-A*32 allele as a prognostic indicator of COVID-19 severity

In a new study, researchers evaluated the association between human leukocyte antigens alleles and the severity of COVID-19.

2 Mar 2022

How effective is mRNA vaccination in multiple myeloma patients?

In a new study, researchers have been investigating the protection offered by the SARS-CoV-2 vaccine in patients suffering from multiple myeloma.

2 Mar 2022

Study focuses on the potential indirect effects of COVID-19 on tinnitus severity

Tinnitus, most often described as "ringing" in the ears even though no external sound is present, also can be perceived as humming, hissing, buzzing or roaring sounds.

2 Mar 2022

Novel drug candidate protects lab mice against cognitive decline by reducing brain inflammation

An anti-inflammatory drug candidate, known as 3,6'-dithiopomalidomide (DP), designed by researchers at the National Institute on Aging, protected lab mice against cognitive decline by reducing brain inflammation.

2 Mar 2022

Triple drug regimen proven effective against non-structural protein-1 of SARS-CoV-2

Researchers evaluated the synergistic activity of drugs acting against non-structural protein 1 of SARS-CoV-2 to decrease the viral infectivity.

2 Mar 2022

Study shows the viability of lung transplants in patients with COVID-19-associated ARDS

Patients with COVID-19-associated acute respiratory distress syndrome who received lung transplants had similar outcomes, compared to transplant patients without COVID-19, according to a Northwestern Medicine study published in JAMA.

2 Mar 2022

Dual therapeutic potential of zapnometinib against COVID-19

Researchers assessed the impact of the drug zapnometinib on human immune response against coronavirus disease 2019.

2 Mar 2022

Similarities between SARS-CoV-2 and human retroelements explored

A new study investigated the similarities between SARS-CoV-2 and human retroelements.

2 Mar 2022

Durability of immunity to SARS-CoV-2 reinfection among initially unvaccinated individuals with previous SARS-CoV-2 infection

An new study published presents evidence that a prior history of infection with SARS-CoV-2 provides immunity that prevents reinfection for at least a year.

2 Mar 2022

Medical Condition News

UH researcher receives $2 million to develop drugs for traditionally undruggable targets in cancer

Study finds new benchmark for measuring the risk of death from heart surgery

Novel MRI approach can identify brain cell damage in people at early stages of Alzheimer's

Exposure to more green space during the pandemic linked to less depression and anxiety

Researchers propose potential fixes to develop evidence-based diagnostic criteria for FMDs

Nicotinamide riboside supplement shows promise as a potential therapy for Parkinson’s disease

Crowdfunding helps young cancer survivors to pay medical bills, but at a cost

Using Hla-A*32 allele as a prognostic indicator of COVID-19 severity

How effective is mRNA vaccination in multiple myeloma patients?

Study focuses on the potential indirect effects of COVID-19 on tinnitus severity

Novel drug candidate protects lab mice against cognitive decline by reducing brain inflammation

Triple drug regimen proven effective against non-structural protein-1 of SARS-CoV-2

Study shows the viability of lung transplants in patients with COVID-19-associated ARDS

Dual therapeutic potential of zapnometinib against COVID-19

Similarities between SARS-CoV-2 and human retroelements explored

Durability of immunity to SARS-CoV-2 reinfection among initially unvaccinated individuals with previous SARS-CoV-2 infection

Study explores signature gut microbiome connection with immune checkpoint inhibitor response in advanced melanomas

Understanding the evolutionary mutational patterns of chronic SARS-CoV-2 infection

Study reports substantial loss of protection one month after complete SARS-CoV-2 BNT162b2 immunization in children

More evidence points to the Wuhan Market as a source of the COVID-19 pandemic

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News